Cargando…

Pulmonary side effects of nivolumab in a patient treated for gynecological malignancy

We report a case of a 26-year-old female patient treated with nivolumab for peritoneal implants from small-cell ovarian cancer. Pulmonary changes were depicted on follow-up examinations, namely, consolidations and scattered ground glass opacities, without any remarkable pulmonary complaints or labor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ip, Joana, Beliao, Sara, Valente-Matos, Rogerio, Gil, Nuno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966623/ https://www.ncbi.nlm.nih.gov/pubmed/29849854 http://dx.doi.org/10.1016/j.radcr.2018.02.015

Ejemplares similares

Development of Extragenital Lichen Sclerosus in Malignant Melanoma Patients Treated With Ipilimumab in Combination With Nivolumab
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2020)

Disparities in Gynecological Malignancies
por: Chatterjee, Sudeshna, et al.
Publicado: (2016)

SOX9: Advances in Gynecological Malignancies
por: Chen, Huan, et al.
Publicado: (2021)

Editorial: The role of imaging in gynecological malignancies
por: Han, Kathy, et al.
Publicado: (2023)

The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies
por: Reinbolt, Raquel E., et al.
Publicado: (2013)

Editorial: Advances of Targeted Therapy in Gynecologic Malignancies
por: Qiu, Haifeng, et al.
Publicado: (2022)

Editorial: Molecular predictive pathology in gynecologic malignancies
por: Malapelle, Umberto, et al.
Publicado: (2023)

Assessment of Setup Errors in Gynecological Malignancies Treated With Radiotherapy Using Onboard Imaging
por: LNU, Aparajeeta, et al.
Publicado: (2023)

Editorial: Harnessing DNA Damage Response in Gynecologic Malignancies
por: Tse, Ka Yu, et al.
Publicado: (2022)

Editorial: Diagnosis and treatment of gynecologic malignancies during pregnancy
por: Wang, Yudong, et al.
Publicado: (2023)

Survival and Control Prognosticators of Recurrent Gynecological Malignancies of the Pelvis and Para-aortic Region Treated with Stereotactic Body Radiation Therapy
por: Hasan, Shaakir, et al.
Publicado: (2016)

MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies
por: Duică, Florentina, et al.
Publicado: (2020)

The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies
por: Marinelli, Oliviero, et al.
Publicado: (2019)

Editorial: Molecular pathology and computational image analyses in gynecologic malignancies
por: Malapelle, Umberto, et al.
Publicado: (2022)

Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy?
por: Villegas-Pineda, Julio César, et al.
Publicado: (2023)

Editorial: Fertility-preserving and fertility-sparing treatment approaches in gynecologic malignancies
por: Raimondo, Diego, et al.
Publicado: (2023)

Case Report: Differential Genomics and Evolution of a Meningeal Melanoma Treated With Ipilimumab and Nivolumab
por: Burgos, Remberto, et al.
Publicado: (2022)

Prognostic Impact of Baseline Neutrophil-to-Eosinophil Ratio in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Therapy in Second or Later Lines
por: Gil, Lucia, et al.
Publicado: (2022)

Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies
por: Kunos, Charles A., et al.
Publicado: (2012)

A Cartography of Siglecs and Sialyltransferases in Gynecologic Malignancies: Is There a Road Towards a Sweet Future?
por: Haas, Quentin, et al.
Publicado: (2018)

High-dose-rate interstitial brachytherapy for gynecologic malignancies—dosimetric changes during treatment period
por: Onoe, Tsuyoshi, et al.
Publicado: (2013)

A new technique for performing interstitial implants for gynecologic malignancies using transvaginal ultrasound guidance
por: Yan, Xiao-Jing, et al.
Publicado: (2022)

Application of ERAS concept in clinical nursing of patients with advanced cancer pain of gynecological malignant tumors
por: Liao, Haijing, et al.
Publicado: (2023)

Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect
por: Merlino, Dante J., et al.
Publicado: (2020)

Primary amelanotic malignant melanoma of the male urethra with inguinal lymph node metastasis successfully controlled by nivolumab: A case report
por: Tokita, Takashi, et al.
Publicado: (2018)

Myocardial edema during chemotherapy for gynecologic malignancies: A cardiac magnetic resonance T2 mapping study
por: Yang, Meng-Xi, et al.
Publicado: (2022)

Tuberculosis Infection in a Patient Treated With Nivolumab for Non-small Cell Lung Cancer: Case Report and Literature Review
por: van Eeden, Ronwyn, et al.
Publicado: (2019)

Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy
por: Jiang, Meilin, et al.
Publicado: (2020)

Lymph Node Metastasis From Gastroesophageal Cancer Successfully Treated by Nivolumab: A Case Report of a Young Patient
por: Kashima, Shin, et al.
Publicado: (2019)

Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience
por: Bimbatti, Davide, et al.
Publicado: (2022)

Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial
por: Klein, Oliver, et al.
Publicado: (2021)

Analysis of Applicator Insertion Related Acute Side Effects for Cervical Cancer Treated With Brachytherapy
por: Chen, Jiajun, et al.
Publicado: (2021)

Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification
por: Liu, Yanyang, et al.
Publicado: (2021)

Efficacy of Pembrolizumab and Nivolumab in Crossing the Blood Brain Barrier
por: Abid, Haisam, et al.
Publicado: (2019)

The Relevance of Gynecologic Oncologists to Provide High-Quality of Care to Women with Gynecological Cancer
por: Minig, Lucas, et al.
Publicado: (2016)

Risk factors, microbiology and management of infected lymphocyst after lymphadenectomy for gynecologic malignancies
por: Ma, Xuegong, et al.
Publicado: (2018)

The Biological Relevance of NHERF1 Protein in Gynecological Tumors
por: Sonnessa, Margherita, et al.
Publicado: (2022)

Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
por: Kim, Jwa Hoon, et al.
Publicado: (2022)

Long Term Remission and Cardiac Toxicity of a Combination of Ipilimumab and Nivolumab in a Patient With Metastatic Head and Neck Carcinoma After Progression Following Nivolumab Monotherapy
por: Schwab, Katjana S., et al.
Publicado: (2019)

Editorial: Methods in gynecological oncology
por: Perelli, Federica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jcg0hk6lvdlnkqtg253k8km1ab